Embolic events are highly prevalent in patients with thyrotoxic atrial fibrillation, highlighting the potential need for routine anticoagulation in this population.
Answers are grounded in this paper and cite their sources.
High embolic rates in thyrotoxic AF; hypothesis-generating and should not yet change practice.
Of 210 patients with thyrotoxicosis, 21 (10%) had atrial fibrillation. Five of these patients (24%) had systemic emboli (which were multiple in three patients, one of whom died) and two other patients had pulmonary embolism. Embolic disease is common in thyrotoxic atrial fibrillation, and anticoagulant therapy should be considered for all patients.
No takes yet. Share an insight, caveat, or question.
Yuen et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: